- Home
- AMD vs MRK Comparison
AMD vs MRK Comparison
Compare AMD & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMD | MRK |
|---|---|---|
| Founded | 1969 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 325.9B | 268.7B |
| IPO Year | 2002 | 1994 |
Fundamental Metrics
Financial Performance| Metric | AMD | MRK |
|---|---|---|
| Price | $203.15 | $120.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 34 | 15 |
| Target Price | ★ $261.21 | $123.67 |
| AVG Volume (30 Days) | ★ 26.8M | 6.9M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.88% |
| EPS Growth | ★ 165.00 | 8.01 |
| EPS | 2.65 | ★ 7.28 |
| Revenue | N/A | ★ $65,011,000,000.00 |
| Revenue This Year | $35.50 | $3.74 |
| Revenue Next Year | $42.58 | $5.47 |
| P/E Ratio | $74.10 | ★ $16.19 |
| Revenue Growth | N/A | ★ 1.31 |
| 52 Week Low | $76.48 | $75.40 |
| 52 Week High | $267.08 | $125.14 |
Technical Indicators
Market Signals| Indicator | AMD | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 58.67 |
| Support Level | $194.14 | $113.27 |
| Resistance Level | $215.92 | $125.14 |
| Average True Range (ATR) | 8.70 | 2.43 |
| MACD | 0.79 | 0.37 |
| Stochastic Oscillator | 37.41 | 84.98 |
Price Performance
Historical ComparisonAbout AMD Advanced Micro Devices Inc.
Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers (including artificial intelligence), industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. However, AMD is emerging as a prominent player in AI GPUs and related hardware. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).